Introduction Merger control remains an active area of antitrust enforcement in Europe as well as other parts of the world. The global merger boom of the last few years continues to raise significant challenges for enforcers, not least through the recent mega-mergers in the pharmaceuticals, agrochemical and IT industries. In their global survey of merger control enforcement in 2017, Allen & Overy claim that the trend of increased intervention by antitrust authorities they observed in 2016 has continued. [1] More deals were prohibited or abandoned, representing a much higher value than in 2016, and the number of deals subject to remedies remained consistently high. My own analysis of the statistics published by DG Comp shows that out of a total of 68 interventions by the EC over
Share on
|
|
Merger remedies and competition law: An overview of recent EU case law and international policy developments
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.
